Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors
- 1 September 2014
- journal article
- case report
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 25 (8) , 857-867
Abstract
Immune adjuvants have been used in cancer biotherapies to stimulate immune response to tumor cells. Despite their potential as anticancer reagents, there are several impediments to their use in clinical applications. In this study, we aim to modify the existing tuftsin structure and evaluate its antitumor activity in preclinical models. We synthesized a novel tuftsin derivative, namely, the T peptide (TP), by linking four tuftsin peptides, which showed enhanced stability in vivo. We then evaluated its anticancer activity in a postoperative residual tumor model in mice, where we surgically removed most of the primary tumor from the host, a procedure mimicking clinically postoperative patients. Despite the limited effect in intact solid tumors, TP strongly inhibited relapsed growth of residual tumors in postsurgical mice. Surgical resection of tumors accelerated residual tumor growth, but TP slowed down this process significantly. Interestingly, TP showed similar effects in human xenograft residual models. As an immunomodulator, TP could synergize the functions of macrophages, thus inhibiting the growth of cocultured tumor cells in vitro. Furthermore, TP could shift the macrophages to the tumor-suppressive M1 type and mobilize them to produce elevated cytotoxic TNF-α and NO. As a result, TP effectively prolonged the survival time of tumor-resected mice. Using the postoperative residual tumor models, we provide a body of evidence showing the antitumor activity of TP, which causes no obvious toxicity. Our study highlights the potential of TP as a postoperative adjuvant in cancer therapies.Keywords
This publication has 19 references indexed in Scilit:
- Modulation of macrophage phenotype by cell shapeProceedings of the National Academy of Sciences, 2013
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the LiteraturePLOS ONE, 2012
- Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsinVaccine, 2012
- Immune microenvironments in solid tumors: new targets for therapyGenes & Development, 2011
- Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical ApproachAnnals of Surgical Oncology, 2010
- Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic interventionSeminars in Cancer Biology, 2006
- Rheological Characterization of Polysaccharide−Poly(ethylene glycol) Star Copolymer HydrogelsBiomacromolecules, 2005
- Tuftsin and Substance P as Modulators of Phagocyte Functions1982
- Antitumor effect of tuftsinMolecular and Cellular Biochemistry, 1981
- The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological propertiesBiochimica et Biophysica Acta (BBA) - Protein Structure, 1973